Evolus (EOLS) Other Non-Current Liabilities (2018 - 2021)
Evolus' (EOLS) quarterly Other Non-Current Liabilities came in at $44.7 million in Q4 2021, up 7.69% YoY from $41.5 million in Q4 2020, and up 794.8% on a QoQ basis from $5.0 million in Q3 2021.
Evolus (EOLS) Other Non-Current Liabilities (2018 - 2021) Analysis & Trends
Evolus (EOLS) has 4 years of Other Non-Current Liabilities data on file, last reported at $44.7 million in Q4 2021.
- Quarterly Other Non-Current Liabilities rose 7.69% year-over-year to $44.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $44.7 million (up 7.69% YoY) and the FY2021 annual result came in at $44.7 million, up 7.69% from the prior year.
- Other Non-Current Liabilities rose to $44.7 million in Q4 2021, from $5.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $51.1 million in Q3 2018 to a low of $5.0 million in Q1 2021.
- A 4-year average of $35.7 million and a median of $44.7 million in 2019 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2019 — Other Non-Current Liabilities increased 13.05% — and 2021, when it plunged 85.39%.
- Tracing EOLS's Other Non-Current Liabilities over 4 years: stood at $50.2 million in 2018, then declined by 10.99% to $44.7 million in 2019, then fell by 7.02% to $41.5 million in 2020, then advanced by 7.69% to $44.7 million in 2021.
- The last three Other Non-Current Liabilities figures came in at $44.7 million (Q4 2021), $5.0 million (Q3 2021), and $5.0 million (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 44.74 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 5.00 Mn |
| Mar 31, 2021 | 5.00 Mn |
| Dec 31, 2020 | 41.55 Mn |
| Mar 31, 2020 | 34.22 Mn |
| Dec 31, 2019 | 44.68 Mn |
| Jun 30, 2019 | 47.17 Mn |
| Mar 31, 2019 | 45.90 Mn |
| Dec 31, 2018 | 50.20 Mn |
| Sep 30, 2018 | 51.10 Mn |
| Jun 30, 2018 | 48.80 Mn |
| Mar 31, 2018 | 40.60 Mn |